To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Most Popular in Claims/Labeling
- 1Unilever’s TRESemmé Shampoo Alleged to Cause Irritation, Hair Loss
- 2J&J, Walgreens-Boots, L'Oréal, Maybelline and E.L.F. Named in 'Oil-free' False Advert Suits
- 3FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 4Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure
- 5Natural Advocate: USDA BioPreferred Label Quantifies Bio-based Claims
- 6The Face Value of SPF Testing: Rethinking Sun Protection Claims
- 7Making Hair (Claims) Do What You Want
- 8U.S. Federal Trade Commission Lays Down the Law on Deceptive CBD Claims
- 9NSF International Launches 455 GMP Certification
- 10Certifying Hair Product Claims
- FDA Warning Expands: More Hand Sanitizer Recalls Due to Methanol
7/7/2020, Michele Behrens
- NSF International to Offer GMRA Certification and Audits
5/5/2020, Rachel Grabenhofer
- Cosmeservice Speeds Cleanser-to-Hand Sanitizer Registration in the EU
5/15/2020, Michele Behrens
- Unilever’s TRESemmé Shampoo Alleged to Cause Irritation, Hair Loss
1/4/2021, Michele Behrens
- Beauty Accelerate Virtual: Fragrance Allergens—Are You Compliant?
10/6/2020, Rachel Grabenhofer